Hodgkin's Lymphoma, Lymphocytic-Histiocytic Predominance — NIH Grants & Funding

MONDO:0004604

Hodgkin's Lymphoma, Lymphocytic-Histiocytic Predominance has emerging NIH research funding with 1 grant totaling $570K.

1funded grants from NIH

Portfolio: $285KCumulative: $570K1 active0 completed1 PIs1 institutions

Clinical

NIH fiscal year (Oct–Sep)

$285K

FY24

$285K

FY25

Comprehensive gap analysis requires both grant and publication data for Hodgkin's Lymphoma, Lymphocytic-Histiocytic Predominance.

Explore the publication landscape to help build the cross-domain picture.

ClinicalK08Active

Binkley, Michael·STANFORD UNIVERSITY·STANFORD, CA

$284,784 (FY2025)

STANFORD UNIVERSITY$285K

CA1 grantBinkley, Michael

Binkley, Michael$285K

STANFORD UNIVERSITY·1 grant

Clinical

Track funding opportunities for Hodgkin's Lymphoma, Lymphocytic-Histiocytic Predominance.

Follow this disease to be notified about new NIH grants and funding changes.

Already have an account? Sign in to manage your watchlists.